Diseases assc w Metabolic Pathways Flashcards

1
Q

hexokinase

A

traps glucose in cell by phosphorylating glucose to glucose-6P. Uses ATP. First step of glycolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

PFK-1

A

rate limiting enzyme of glycolysis; uses ATP to convert fructose-6P to fructose-1,6BP. Regulates what goes into glycolysis.

  • Activated by AMP, Fructose-2,6-BP.
  • Inhibited by ATP, Citrate from TCA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

glyceraldehyde-3P dehydrogenase

A

uses NAD+ to convert glyceraldehyde 3P to 1,3-BPG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

phosphoglycerate kinase

A

generates 2 ATP by converting 1,3-BPG into 3-phosphoglycerate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pyruvate kinase

A

bottleneck enzyme of glycolysis, controls rate of exit of glycolysis by generating pyruvate; also generates 2 ATP.

  • Activated by F-1,6-BP (if PFK1 is moving faster than PK, F-1,6BP will build up and bind to PK to stimulate)
  • Inhibited by ATP, Acetyl-CoA from TCA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

PFK2

A

enzyme that converts fructose-6P to fructose-2,6-BP, which stimulates PFK-1. Allows glycolysis to bypass inhibition by citrate/acetyl coA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

lactate dehydrogenase

A

enzyme that converts pyruvate to lactate using NADH. There is an increased amt of lactic acid during hypoxic conditions - symptoms = muscle cramps, exhaustion, nausea, malaise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

hemolytic anemia

A

defective glycolysis causes RBCs to not be able to use energy from ATP to pump Na+ ions back out of the cell. Leads to the cell swelling up and exploding –> echinocytes, hemolysis. Leads to lactic acidosis if anemia is severe enough because lack of RBCs to carry O2 makes for worsening hypoxic conditions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

other role of glycolysis in RBCs

A

Rapoport-Luebering glycolytic bypass - unique to RBCs. Uses BPG mutase to convert 1,3BPG to DPG.

DPG binds hemoglobin and stabilizes its low O2 affinity state. This helps hemoglobin deliver O2 to tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

too much DPG leads to

A

right shift of Hb curve, poor loading of O2 onto RBCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

too little DPG leads to

A

left shift of Hb curve, poor offloading of O2 to tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

fetal hemoglobin

A

does not respond to DPG, thus always has a high affinity for O2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

defect in hexokinase or PFK-1

A

not enough DPG, left shift of Hb curve = poor offloading

More severe, treat with blood transfusions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

defect in pyruvate kinase

A

too much DPG, right shift in Hb curve = poor onloading

Milder, treat with oxygen therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

fasting state

A

high glucagon/insulin ratio, liver releases glucose (glycogenolysis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

fed state

A

high insulin/glucagon ratio, liver stores glucose (glycogenesis)

17
Q

prolonged fasting state

A

high glucagon/insulin ratio, body switches from glycogenolysis to gluconeogenesis after about 24 hours

18
Q

glucokinase

A

the liver expresses this to capture dietary carbs, has lower affinity (higher Km) for glucose than hexokinase 1 (found in all other cells)

19
Q

UDP glucose

A

glucose-6P is converted to UDP-glucose by UDP-Glucose-Pyrophosphorylase. UDP glucose is the substrate for glycogenesis as well as for glycoproteins and glycolipids.

Normal glucose is not reactive enough to be added onto glycogen, so must be energized by adding UDP.

20
Q

glycogenesis

A
  1. glycogenin autoglycosylates itself with UDP-glucose.
  2. glycogen synthase adds glucose monomers with a-1,4 bonds.
  3. branching enzyme breaks an a-1,4 bond and transfers the chain after that point onto a branch formed by an a-1,6 bond.
  4. Both chains can be elongated by glycogen synthase.
21
Q

glycogenolysis

A
  1. phosphorylase breaks a-1,4 bonds to release glucose 1P but falls off at branching point.
  2. debranching enzyme breaks the a-1,4 bond one monomer away from the branching point, then breaks the a-1,6 bond at the branching point, releasing the glucose.
  3. phosphorylase can now return to original chain and continue breaking off monomers
22
Q

allosteric activation/inhibition of glycogenesis

A

High glucose = glucose 6-P builds up and activates glycogen synthase; glucose itself inhibits phosphorylase, preventing glycogenolysis

23
Q

glucagon

A

“glucose in the blood is low”

Receptors found in liver only; causes increased glycogenolysis, gluconeogenesis

24
Q

insulin

A

“there is too much glucose in the blood”

Receptors found in liver and muscle; causes increased glycogenesis, decreased gluconeogenesis

25
Q

epinephrine

A

“we are going to need more glucose”

Receptors found in liver and muscle; causes increased glycogenolysis and increased gluconeogenesis

26
Q

How does epinephrine/glucagon tell the liver to increase glycogenolysis?

A

Using GPCR, cAMP, PKA pathway. PKA activates phosphorylase kinase and deactivates glycogen synthase. Activated phosphorylase kinase activates phosphorylase = glycogenolysis.

27
Q

How does insulin decrease glycogenolysis?

A

removes phosphate from glycogen machinery which inactivates the degrading enzymes and activates glycogen synthase

28
Q

Regulation of glycogenolyis in skeletal muscle

A

unique muscle-specific glycogen phosphorylase has an AMP allosteric activation site – is activated by contraction (influx of Ca2+) and energy need (increased AMP).
Activation of glycogenolysis and glycolysis is coupled in skeletal muscle by AMP.

29
Q

Cori and glucose-alanine cycles

A
  1. Pyruvate may build up in a working muscle cell, will be converted into lactate and alanine and secreted into bloodstream.
  2. Liver uptakes the lactate/alanine, converts back to pyruvate, and uses gluconeogenesis to turn it into glucose.
30
Q

defects in gluconeogenesis

A

The inability to convert lactic acid into glucose leads to hypoglycemia, lactatemia, and lactic acidosis.
Excessive consumption of alcohol can overwhelm the liver’s ability to use NAD+ to convert lactate to glucose = lactic acidosis.

31
Q

glycogen storage diseases

A

Abnormal synthesis or degradation of glycogen. Caused by mutation or altered expression of enzymes involved in the regulation of glycogen metabolism, symptoms can be mild to severe. Most of the diseases are due to decreased degradation.
Liver defect: inter-meal hypoglycemia and hepatomegaly
Muscle defect: normal blood glucose but exercise intolerance, muscle cramping, wasting

32
Q

Von Gierke’s

A

defect of liver glucose-6-phosphatase, dietary glucose builds up in the liver over time, cannot be released. Severe hepatomegaly, severe hypoglycemia.

33
Q

McArdle’s

A

defect of muscle phosphorylase; muscle cells unable to breakdown glycogen. Causes muscle pain with exercise, normal blood glucose levels.

34
Q

Hers’ disease

A

defect of liver phosphorylase, cannot degrade glycogen as well. Symptoms similar to Von Gierkes but milder.

35
Q

Cori’s disease

A

defect in debranching enzyme in muscle and liver; causes buildup of abnormal glycogen. Similar symptoms to Von Gierke’s but milder.

36
Q

Andersen’s disease

A

defect in branching enzyme in liver and spleen; causes normal amounts of glycogen but glycogen branches much longer. Causes progressive cirrhosis of the liver and death by age 2.

37
Q

Pompe’s disease

A

defect that causes abnormal glycogen storage in lysosomes in all organs. Caused cardiorespiratory failure by age 2 until myozyme hit the market.